FindTrial
Sign In

Study on the therapeutic effect of new selenium preparation L-selenium-methyl selenocysteine on immune-related skin diseases

Study on the therapeutic effect of new selenium preparation L-selenium-methyl selenocysteine on immune-related skin diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106088
Enrollment
Unknown
Registered
2025-07-17
Start date
2024-05-15
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune - related skin diseases (psoriasis, bullous pemphigoid, IgA vasculitis, atopic dermatitis)

Interventions

Disease group:None
control group:None

Sponsors

Xi'an Jiaotong University Second Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1.Clinically diagnosed as immune - related skin diseases (psoriasis, bullous pemphigoid, IgA vasculitis, atopic dermatitis);

Exclusion criteria

Exclusion criteria: 1.Patients with severe acute infections; 2.patients with immunodeficiency and infectious diseases, HIV patients and syphilis patients; 3.psychiatric patients;

Design outcomes

Primary

MeasureTime frame
Selenium protein;—

Countries

China

Contacts

Public ContactYanyan Zhu

Xi'an Jiaotong University Second Affiliated Hospital

zhuyanyan2018@mail.xjtu.edu.cn+86 15736786051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026